Deep search
Search
Copilot
Images
Videos
Maps
News
Shopping
More
Flights
Travel
Hotels
Real Estate
Notebook
Top stories
Sports
U.S.
2024 Election
Local
World
Science
Technology
Entertainment
Business
More
Politics
Any time
Past hour
Past 24 hours
Past 7 days
Past 30 days
Best match
Most recent
Wegovy, other weight-loss drugs might help with alcoholism, opioid addiction
Weight-loss and diabetes drugs like Ozempic, Wegovy, Mounjaro or Zepbound appear to help people battle alcoholism and opioid addiction, a new study finds.
GLP-1 weight loss drugs may help reduce addiction, overdose risks: Study
Those who took Ozempic or a similar drug had a 40% lower chance of overdosing on opioids and a 50% lower chance of getting drunk compared to those who didn't take the medication, the study found.
Novo Nordisk's Weight Loss Drug Ozempic Associated With Reduced Opioid, Alcohol Use Disorder Incidences, Study Shows
A study found that prescriptions for GIP/GLP-1 RA drugs may reduce opioid overdose and alcohol intoxication rates in patients with OUD and AUD, offering potential new treatments for addiction.
Weight loss injections: How do drugs like Wegovy and Mounjaro work?
Both Wegovy and Mounjaro are given as weekly injections via pre-filled pens that can be self-administered into the upper arm, thigh or stomach. They work as an appetite suppressant by mimicking a hormone called glucagon-like peptide-1 (GLP-1).
Ozempic: Weight Loss Drug May Help With Addiction Too
These medications have been associated with a 40 percent reduction in opioid overdose and 50 percent lower rate of alcohol intoxication.
Weight-loss drugs show promise in tackling opioid and alcohol abuse
Ozempic and similar products cut opioid and alcohol abuse by up to half, according to research that adds to evidence of the hugely popular blockbuster drugs’ broad potential beyond tackling obesity and diabetes.
Could Ozempic and similar drugs be used to treat substance use disorders?
One of the most prominent medical developments in recent years has been the emergence of a class of drugs called glucagon-like peptide-1 receptor agonists (GLP-1 RAs). The best known of these drugs is Ozempic,
Ozempic Could Be Used to Treat Alcohol and Drug Addiction, Study Finds
In a huge new statistical analysis, researchers have found more evidence than ever that drugs like Ozempic can help curb alcohol and opioid addiction. Published in the journal Addiction, this new study saw researchers from Loyola University Chicago sift through more than 1.
Researchers Think Popular Weight Loss Drugs Could Help Lower Opioid Overdose, Alcohol Intoxication Rates
Weight loss drugs such as Ozempic, Wegovy and Mounjaro may lower opioid overdose and alcohol intoxication rates among opioid addicts and alcoholics, respectively, according to a new study by three Loyola University Chicago researchers.
News Medical on MSN
11h
Large-scale human study finds Ozempic (or similar medications) may reduce opioid overdose risk by 40%
A study published in the journal Addiction has found that people with opioid or alcohol use disorder (OUD, AUD) who take ...
Inverse
14h
Ozempic Might Help Treat Two Common Addiction Disorders
A new study from Loyola University demonstrates that GLP-1 receptor agonists like Ozempic can help treat substance use ...
HealthDay on MSN
19h
Diabetes, High BMI, Previous Metformin Common in Teens With Rx for GLP-1 RAs
Patients aged 10 to 17 years who are prescribed glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are more likely to have ...
EurekAlert!
20h
Ozempic (and similar medications) may be the new treatment for opioid and alcohol use disorder
A new study published in the scientific journal Addiction has found that people with opioid or alcohol use disorder (OUD, AUD) who take Ozempic or similar medications to treat diabetic/weight-related ...
21h
on MSN
Ozempic could cut binge drinking and opioid abuse
Ozempic could cut binge drinking and opioid abuse, major research suggests. A US study of more than 800,000 people with a ...
ahajournals.org
6d
Muscle Mass and Glucagon-Like Peptide-1 Receptor Agonists: Adaptive or Maladaptive Response to Weight Loss?
Recent studies have shown that pharmacologic weight loss with glucagon-like peptide-1 receptor agonists (GLP-1 RAs) and ...
Medscape
1d
GLP-1 Receptor Agonists Reduce Suicidal Behavior in Adolescents With Obesity
Glucagon-like peptide 1 receptor agonists (GLP-1 RAs) given to adolescents with obesity was associated with a one-third ...
1d
Diabetes, high BMI, previous metformin prescriptions are common in teens with prescriptions for GLP-1 RAs
Patients aged 10 to 17 years who are prescribed glucagon-like peptide-1 receptor agonists (GLP-1 RAs) are more likely to have ...
healthday on MSN
2d
Risk for Suicidal Ideation, Attempts Down With GLP1-RA Treatment in Teens With Obesity
For adolescents with obesity, glucagon-like peptide 1 receptor agonist (GLP1-RA) treatment is associated with a reduc ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results
Feedback